Indivior (LON:INDV) Trading Down 15.7% – Here’s Why

Indivior PLC (LON:INDV)’s stock price fell 15.7% on Thursday . The company traded as low as GBX 548.71 ($6.95) and last traded at GBX 732 ($9.28). 1,888,371 shares were traded during trading, an increase of 166% from the average session volume of 709,477 shares. The stock had previously closed at GBX 868 ($11.00).

Analyst Upgrades and Downgrades

Separately, Jefferies Financial Group reissued a “buy” rating and set a GBX 1,800 ($22.81) price objective on shares of Indivior in a research note on Tuesday, December 17th.

Indivior Stock Performance

The company has a current ratio of 0.83, a quick ratio of 1.52 and a debt-to-equity ratio of -170.06. The firm has a market cap of £1.14 billion, a PE ratio of -606.93, a P/E/G ratio of -5.57 and a beta of 0.19. The stock’s 50 day moving average price is GBX 924.76 and its 200 day moving average price is GBX 852.88.

About Indivior

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.